Co M - Search Results

1

Telomere length dynamics in human memory T cells specific for viruses causing acute or latent infections.

O'Bryan JM, Woda M, Co M, Mathew A, Rothman AL. O'Bryan JM, et al. Among authors: co m. Immun Ageing. 2013 Aug 26;10(1):37. doi: 10.1186/1742-4933-10-37. Immun Ageing. 2013. PMID: 23971624 Free PMC article.

2

Dynamics of the CD8 T-cell response following yellow fever virus 17D immunization.

Co MD, Kilpatrick ED, Rothman AL. Co MD, et al. Immunology. 2009 Sep;128(1 Suppl):e718-27. doi: 10.1111/j.1365-2567.2009.03070.x. Epub 2009 Feb 11. Immunology. 2009. PMID: 19740333 Free PMC article.

3

Interaction of a dengue virus NS1-derived peptide with the inhibitory receptor KIR3DL1 on natural killer cells.

Townsley E, O'Connor G, Cosgrove C, Woda M, Co M, Thomas SJ, Kalayanarooj S, Yoon IK, Nisalak A, Srikiatkhachorn A, Green S, Stephens HA, Gostick E, Price DA, Carrington M, Alter G, McVicar DW, Rothman AL, Mathew A. Townsley E, et al. Among authors: co m. Clin Exp Immunol. 2016 Mar;183(3):419-30. doi: 10.1111/cei.12722. Epub 2015 Nov 24. Clin Exp Immunol. 2016. PMID: 26439909 Free PMC article.

4

CpG Improves Influenza Vaccine Efficacy in Young Adult but Not Aged Mice.

Ramirez A, Co M, Mathew A. Ramirez A, et al. Among authors: co m. PLoS One. 2016 Mar 2;11(3):e0150425. doi: 10.1371/journal.pone.0150425. eCollection 2016. PLoS One. 2016. PMID: 26934728 Free PMC article.

5

Discordance between antibody and T cell responses in recipients of trivalent inactivated influenza vaccine.

Co MD, Orphin L, Cruz J, Pazoles P, Rothman AL, Ennis FA, Terajima M. Co MD, et al. Vaccine. 2008 Apr 7;26(16):1990-8. doi: 10.1016/j.vaccine.2008.02.024. Epub 2008 Feb 26. Vaccine. 2008. PMID: 18339461 Free PMC article.

6

Human cytotoxic T lymphocyte responses to live attenuated 17D yellow fever vaccine: identification of HLA-B35-restricted CTL epitopes on nonstructural proteins NS1, NS2b, NS3, and the structural protein E.

Co MD, Terajima M, Cruz J, Ennis FA, Rothman AL. Co MD, et al. Virology. 2002 Feb 1;293(1):151-63. doi: 10.1006/viro.2001.1255. Virology. 2002. PMID: 11853408 Free article.

7

The safety and tolerability of an HIV-1 DNA prime-protein boost vaccine (DP6-001) in healthy adult volunteers.

Kennedy JS, Co M, Green S, Longtine K, Longtine J, O'Neill MA, Adams JP, Rothman AL, Yu Q, Johnson-Leva R, Pal R, Wang S, Lu S, Markham P. Kennedy JS, et al. Among authors: co m. Vaccine. 2008 Aug 18;26(35):4420-4. doi: 10.1016/j.vaccine.2008.05.090. Epub 2008 Jun 25. Vaccine. 2008. PMID: 18588934 Free PMC article. Clinical Trial.

8

Cross-reactive human B cell and T cell epitopes between influenza A and B viruses.

Terajima M, Babon JA, Co MD, Ennis FA. Terajima M, et al. Among authors: co md. Virol J. 2013 Jul 26;10:244. doi: 10.1186/1743-422X-10-244. Virol J. 2013. PMID: 23886073 Free PMC article. Review.

9

Induction of H7N9-Cross-Reactive Antibody-Dependent Cellular Cytotoxicity Antibodies by Human Seasonal Influenza A Viruses that are Directed Toward the Nucleoprotein.

Jegaskanda S, Co MDT, Cruz J, Subbarao K, Ennis FA, Terajima M. Jegaskanda S, et al. Among authors: co mdt. J Infect Dis. 2017 Mar 1;215(5):818-823. doi: 10.1093/infdis/jiw629. J Infect Dis. 2017. PMID: 28011910 Free PMC article.

10

Age and different influenza viruses.

Terajima M, Co MD, Ennis FA. Terajima M, et al. Among authors: co md. Lancet Infect Dis. 2014 Feb;14(2):101. doi: 10.1016/S1473-3099(13)70698-4. Lancet Infect Dis. 2014. PMID: 24457169 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

204 results

Search Page

Filters